Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2013
12/04/2013CN203315381U Nanometer anti-AIDS (Acquired Immune Deficiency Syndrome) and anti-inflammatory medicament with radiotherapy function
12/04/2013CN101272810B A radioactive surface source and a method for producing the same
12/03/2013US8597614 Diagnosis and treatment of mood disorders
12/03/2013US8597613 Radiolabeled lymphatic staining agents and methods for making
12/03/2013CA2749505C 68ga generator
11/2013
11/28/2013WO2013176698A1 Carboline and carbazole based imaging agents for detecting neurological dysfunction
11/28/2013WO2013176522A1 Method for synthesizing radiopharmaceuticals using a cartridge
11/28/2013WO2013174949A1 Method and apparatus for the production of lead 212 for medical use
11/28/2013WO2013174909A1 Purification of [18f] - fluciclatide
11/28/2013US20130317196 Triazanonane derivatives or pharmaceutically acceptable salt thereof for enhanced fluorine-18 labeling
11/28/2013US20130315827 Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders
11/28/2013US20130315826 Beta-Amyloid Plaque Imaging Agents
11/28/2013US20130315825 Tricyclic heteroaromatic compounds as alpha-synuclein ligands
11/28/2013US20130315824 Radioiodination method
11/28/2013US20130315822 N-alkoxyamide conjugates as imaging agents
11/28/2013US20130315821 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
11/27/2013EP2666787A1 Stable IgG4 antibodies
11/27/2013CN103415304A Method for production of F-18 labeled amyloid beta ligands
11/27/2013CN102391168B Symmetrical difunctional coupling agent and coupled molecular imaging agents thereof
11/26/2013US8591863 Compositions against cancer antigen LIV-1 and uses thereof
11/26/2013US8591862 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
11/26/2013CA2615918C Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
11/26/2013CA2450828C Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin
11/26/2013CA2221690C Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
11/21/2013WO2013173822A1 Constructs for diagnosing and treating inflammatory bowel diseases and colon cancer
11/21/2013WO2013173746A2 Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging
11/21/2013WO2013173716A2 Methods for diagnosing and monitoring eosinophilic esophagitis
11/21/2013WO2013173004A2 Radiopharmaceutical synthesis methods
11/21/2013WO2013172979A1 Methods and compositions for positron emission tomography myocardial perfusion imaging
11/21/2013WO2013171198A1 Set and method for the production of a radiopharmaceutical
11/21/2013WO2013171189A1 Set and method for the production of a radiopharmaceutical
11/21/2013WO2013171188A1 Kit and method for producing a radiopharmaceutical
11/21/2013WO2013171185A1 Set and method for the production of a radiopharmaceutical
11/21/2013WO2013144301A3 Easily purifiable synthon composition
11/21/2013US20130309170 Compositions And Methods For In Vivo Imaging
11/21/2013US20130309169 Sentinel Lymph Node Marker Capable of Multi-Mode Imaging
11/21/2013DE102012208378A1 Satz und Verfahren zur Herstellung eines Radiopharmakons Kit and procedures for preparing a radiopharmaceutical
11/21/2013DE102012208376A1 Satz und Verfahren zur Herstellung eines Radiopharmakons Kit and procedures for preparing a radiopharmaceutical
11/21/2013DE102012208375A1 Satz und Verfahren zur Herstellung eines Radiopharmakons Kit and procedures for preparing a radiopharmaceutical
11/21/2013DE102004043153B4 Erfindung betreffend GLP-1 und Exendin Invention concerning GLP-1 and exendin
11/20/2013EP2044960B1 Phospholipid analogue for the in vivo diagnosis of cancers
11/20/2013EP1683520B1 Water-soluble prodrugs
11/20/2013CN103402550A HER2 binding peptides labelled with a 18F - containing organosilicon compound
11/20/2013CN103402549A Arginase inhibitors and methods of use thereof
11/20/2013CN103402546A Hydrophobic modified peptides for liver specific diagnosis
11/20/2013CN103402545A Hydrophobic modified peptides and their use for liver specific targeting
11/20/2013CN103393695A Methods and compositions for treatment and management of multiple myeloma
11/20/2013CN103393681A Methodand composition for treatment and management of multiple myeloma
11/20/2013CN103393621A System and method for producing multilayered particles, fibers and sprays and method for applying same
11/20/2013CN102600488B Imaging the central nervous system
11/20/2013CN102600487B Imaging the central nervous system
11/20/2013CN101913973B Preparation and use of alkylating agents
11/19/2013US8586089 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids
11/19/2013CA2552356C Catalytic radiofluorination
11/19/2013CA2523627C Use of a tetrapeptide acsdkp analogue resistant to the angiotensin i conversion enzyme, for measuring glomerular filtration rate in a human or an animal and kit containing same
11/19/2013CA2512188C Immunotherapy of b cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins
11/19/2013CA2447139C Specific binding proteins and uses thereof
11/18/2013CA2816070A1 Method and kit for preparing a radiopharmaceutical
11/14/2013WO2013168622A1 Imaging marker and utilization thereof
11/14/2013WO2013167756A1 Radio-pharmaceutical complexes
11/14/2013WO2013167755A1 Radio-pharmaceutical complexes
11/14/2013WO2013167754A1 Radio-pharmaceutical complexes
11/14/2013WO2013167653A1 18f-labelled folate/antifolate analogues
11/14/2013WO2013167130A1 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING
11/14/2013US20130303757 Polymer precursors of radiolabeled compounds, and methods of making and using the same
11/14/2013US20130302248 Imaging Agents for Detecting Neurological Disorders
11/14/2013US20130302247 Synthesis of fluoroarachidonic acid and methods of use thereof
11/14/2013US20130302246 Compositions and methods for delivering a substance to a biological target
11/14/2013US20130302245 Image-guided therapy of myocardial disease: composition, manufacturing and applications
11/14/2013US20130302244 Method of preparing iodine seed for treating eye disease or cancer, and iodine seed prepared thereby
11/14/2013US20130302243 Radiolabeled nanosystem, process for the preparation thereof and its use
11/14/2013US20130302236 Gamma radiation source
11/14/2013DE102013202897A1 Verfahren zur Herstellung eines Iod-Seeds für die Behandlung einer Augenerkrankung oder Krebserkrankung sowie dadurch hergestelltes Iod-Seed A process for producing an iodine-Seeds for treating an ocular disease or cancer, and thereby produced iodine Seed
11/13/2013EP2661321A1 Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure
11/13/2013EP2661284A1 Her2 binding peptides labelled with a 18f - containing organosilicon compound
11/13/2013CN103387259A Method of producing iodine seed used for treating eye disease or cancer, and iodine seed prepared by using the same
11/12/2013US8580230 Materials and methods for MRI contrast agents and drug delivery
11/12/2013US8580229 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies
11/12/2013CA2565250C Cysteamines for treating complications of hypercholesterolemia and diabetes
11/12/2013CA2524466C Prosthetic groups useful in the synthesis of radiopharmaceutical compounds
11/07/2013WO2013165592A1 Treatment of latent hiv infection
11/07/2013WO2013114204A9 A method of using adenosine and dipyridamole for pharmacologic stress testing, with specific compositions, unit dosage forms and kits
11/07/2013US20130295011 Bacterial nitroreductase enzymes and methods relating thereto
11/07/2013US20130295010 Her2 binding peptides labelled with a 18f - containing organosilicon compound
11/07/2013US20130295009 Method of treating inflammation
11/07/2013US20130295008 Alpha Emitting Constructs and Uses Thereof
11/07/2013US20130295007 Anti-pmel17 antibodies and immunoconjugates
11/07/2013US20130295006 Pharmacokinetic determination of intravitreal agents
11/06/2013EP2658581A1 A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid useful for the localization of radionuclides for diagnostic and therapeutic purposes
11/06/2013EP2658580A1 Arginase inhibitors and methods of use thereof
11/06/2013CN102727913B Preparation method of iodine-labeled gelatin microspheres with high labeling rate
11/06/2013CN101723846B Novel 18F labeled p-nitro benzoyl amino acid derivatives, preparation method and application thereof in tumor imaging
11/06/2013CN101522624B Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
11/05/2013US8575100 Tc and Re labeled radioactive glycosylated octreotide derivatives
11/05/2013US8574575 RS7 antibodies
11/05/2013US8574546 Substituted aryl-fluoroborates as imaging agents
11/05/2013US8574545 Labeled iodinated tropane formulation
11/05/2013US8574544 Pharmaceutical composition of nanoparticles
11/05/2013US8574543 Method of isotope labeling and determining protein synthesis, quantitation and protein expression
11/05/2013CA2690395C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 243